Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.51T | 1.43T | 1.85T | 1.58T | 1.61T | 1.50T |
Gross Profit | 1.69T | 1.43T | 1.29T | 989.30B | 964.98B | 825.68B |
EBITDA | 637.61B | 635.04B | 488.90B | 280.08B | 218.35B | 125.95B |
Net Income | 453.16B | 442.56B | 340.37B | 251.10B | 183.84B | 95.66B |
Balance Sheet | ||||||
Total Assets | 24.07T | 23.64T | 19.58T | 17.53T | 15.74T | 13.77T |
Cash, Cash Equivalents and Short-Term Investments | 1.35T | 1.90T | 1.64T | 2.14T | 1.82T | 1.60T |
Total Debt | 2.06T | 2.01T | 1.84T | 1.59T | 1.40T | 1.99T |
Total Liabilities | 21.20T | 20.94T | 17.37T | 15.65T | 14.07T | 12.48T |
Stockholders Equity | 2.73T | 2.56T | 2.14T | 1.82T | 1.58T | 1.23T |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.54T | -62.39B | 562.51B | 1.36T | 776.91B |
Operating Cash Flow | 0.00 | 1.57T | -37.71B | 581.11B | 1.38T | 795.65B |
Investing Cash Flow | 0.00 | -1.46T | -680.05B | -393.21B | -629.87B | -423.08B |
Financing Cash Flow | 0.00 | 2.47T | 247.91B | 174.51B | -546.67B | 29.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $119.33B | 19.63 | 17.89% | 0.71% | 22.15% | 12.13% | |
74 Outperform | $67.83B | 9.42 | 20.65% | 8.02% | -6.74% | 5.13% | |
73 Outperform | $180.35B | 23.39 | 14.51% | 0.86% | 13.13% | 0.54% | |
72 Outperform | $62.99B | 13.21 | 8.73% | 4.87% | -2.65% | -14.84% | |
70 Outperform | $30.14B | 9.62 | 10.61% | 1.26% | -9.78% | 27.43% | |
70 Outperform | $20.12B | 16.52 | 10.89% | 4.99% | -3.94% | 31.52% | |
67 Neutral | $16.85B | 11.65 | 9.71% | 3.90% | 11.61% | -9.60% |